323 related articles for article (PubMed ID: 35721725)
1. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.
Yang Z; Cai X; Xu X; Xu Z; Ye S; Wang Y; Hong Y; Shen B; Liao Q; Xie Z; Wang X
Anal Biochem; 2022 Jun; 647():114665. PubMed ID: 35339450
[TBL] [Abstract][Full Text] [Related]
3. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
Fukushima T; Umino M; Sakamoto T; Onozato M
Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
[TBL] [Abstract][Full Text] [Related]
4. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
5. Relationship of tryptophan metabolites with the type and severity of multiple sclerosis.
Isık SMT; Onmaz DE; Ekmekci AH; Ozturk S; Unlu A; Abusoglu S
Mult Scler Relat Disord; 2023 Sep; 77():104898. PubMed ID: 37481818
[TBL] [Abstract][Full Text] [Related]
6. Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus.
Gelpi M; Ueland PM; Trøseid M; Mocroft A; Lebech AM; Ullum H; Midttun Ø; Lundgren J; Nielsen SD
J Infect Dis; 2020 Jan; 221(3):419-427. PubMed ID: 31538186
[TBL] [Abstract][Full Text] [Related]
7. Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome.
Chojnacki C; Błońska A; Konrad P; Chojnacki M; Podogrocki M; Poplawski T
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904262
[TBL] [Abstract][Full Text] [Related]
8. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Kozhevnikova MV; Krivova AV; Korobkova EO; Ageev AA; Shestakova KM; Moskaleva NE; Appolonova SA; Privalova EV; Belenkov YN
Kardiologiia; 2022 Nov; 62(11):40-48. PubMed ID: 36521043
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
11. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
[TBL] [Abstract][Full Text] [Related]
12. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.
Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR
Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802
[TBL] [Abstract][Full Text] [Related]
14. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
16. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
17. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
[TBL] [Abstract][Full Text] [Related]
18. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
19. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
Savitz J
Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
